SCHEMBL11538641

SCHEMBL11538641

O=c1ccccn1C(c1ccc(Cl)cc1)c1ccc(Cl)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 6/20 0.46
HSD17B10 Q99714 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.41
CHRM2 P08172 2/20 0.40
HTR1A P08908 2/20 0.40
ADRA2A P08913 2/20 0.40
CHRM1 P11229 2/20 0.40
DRD1 P21728 2/20 0.40
TBXA2R P21731 2/20 0.40
SLC6A2 P23975 2/20 0.40
SLC6A4 P31645 2/20 0.40
ADRA1A P35348 2/20 0.40
DRD3 P35462 2/20 0.40
SLC6A3 Q01959 2/20 0.40
KCNH2 Q12809 2/20 0.40
BCL2 P10415 1/20 0.40
HRH3 Q9Y5N1 1/20 0.40
CYP2D6 P10635 3/20 0.39
TSHR P16473 1/20 0.39
CYP2C19 P33261 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11540241 0.96 CYP19A1 (0.51) CYP19A1HSD17B10CHRM2HTR1AADRA2A
SCHEMBL11538981 0.84 GAA (0.43) CYP19A1CHRM2ADRA2ACHRM1DRD1
SCHEMBL11540954 0.81 CYP19A1 (0.44) CYP19A1HSD17B10L3MBTL1ADRA1AKCNH2
SCHEMBL11537434 0.81 CYP19A1 (0.43) CYP19A1L3MBTL1CYP2D6OPRM1OPRK1
SCHEMBL11539967 0.76 CYP19A1 (0.44) CYP19A1OPRM1OPRK1OPRD1OPRL1
SCHEMBL11545249 0.75 ACP3 (0.46) CYP19A1SLC6A3CYP2D6TSHROPRM1
SCHEMBL9524860 0.75 HSD17B10 (0.41) HSD17B10L3MBTL1DRD3CYP2D6TSHR
SCHEMBL4212713 0.68 F10 (0.56) L3MBTL1SLC6A2SLC6A4SLC6A3ALDH1A1
SCHEMBL1106502 0.67 MAPT (0.38) HSD17B10L3MBTL1TSHRCYP2C19TDP1
SCHEMBL10587078 0.67 PTGS2 (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4138488-A Diphenylmethyl picolinic acid derivatives and their use as anti-acne agents SCHERING CORPORATION (US) 1979-02-06 US disclosed